fluconazole and ponatinib

fluconazole has been researched along with ponatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, C; Jiang, T; Li, J; Liu, L; Liu, NN; Mei, Y; Peng, Y; Tan, J; Wang, H; Wei, L; Zhou, J	1

Other Studies

1 other study(ies) available for fluconazole and ponatinib

Article	Year
Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species. Microbial biotechnology, 2022, Volume: 15, Issue:2 Topics: Antifungal Agents; Antineoplastic Agents; Candida; Drug Repositioning; Fluconazole; Humans; Imidazoles; Microbial Sensitivity Tests; Phylogeny; Proton-Translocating ATPases; Pyridazines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins	2022

Article

Year

Repurposing the FDA-approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species.

Microbial biotechnology, 2022, Volume: 15, Issue:2

Topics: Antifungal Agents; Antineoplastic Agents; Candida; Drug Repositioning; Fluconazole; Humans; Imidazoles; Microbial Sensitivity Tests; Phylogeny; Proton-Translocating ATPases; Pyridazines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins

2022